Pharmaceuticals

Displaying 1 - 7 of 7
Leotta, C. G., Barbaraci, C., Fiorito, J., Coco, A., di Giacomo, V., Amata, E., Marrazzo, A., & Pitari, G. M. (2025). HDAC/σ1R Dual-Ligand as a Targeted Melanoma Therapeutic. Pharmaceuticals, 18(2), 179. https://doi.org/10.3390/ph18020179
Publication Date
Rolfe, N., Dadario, N., Canoll, P., & Bruce, J. (2024). A Review of Therapeutic Agents Given by Convection-Enhanced Delivery for Adult Glioblastoma. Pharmaceuticals, 17(8), 973. https://doi.org/10.3390/ph17080973
Publication Date
McGale, J. P., Howell, H. J., Beddok, A., Tordjman, M., Sun, R., Chen, D., Wu, A. M., Assi, T., Ammari, S., & Dercle, L. (2024). Integrating Artificial Intelligence and PET Imaging for Drug Discovery: A Paradigm Shift in Immunotherapy. Pharmaceuticals, 17(2), 210. https://doi.org/10.3390/ph17020210
Publication Date
Hoertel, N., Rezaei, K., Sánchez-Rico, M., Delgado-Álvarez, A., Kornhuber, J., Gulbins, E., Olfson, M., Ouazana-Vedrines, C., Carpinteiro, A., Cougoule, C., Becker, K. A., Alvarado, J. M., & Limosin, F. (2023). Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study. Pharmaceuticals, 16(8), 1107. https://doi.org/10.3390/ph16081107
Publication Date
Bansode, A. H., Bhoopal, B., Gollapelli, K. K., Damuka, N., Krizan, I., Miller, M., Craft, S., Mintz, A., & Solingapuram Sai, K. K. (2023). Binding Parameters of [11C]MPC-6827, a Microtubule-Imaging PET Radiopharmaceutical in Rodents. Pharmaceuticals, 16(4), 495. https://doi.org/10.3390/ph16040495
Publication Date
Halatsch, M.-E., Dwucet, A., Schmidt, C. J., Mühlnickel, J., Heiland, T., Zeiler, K., Siegelin, M. D., Kast, R. E., & Karpel-Massler, G. (2021). In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma. Pharmaceuticals, 14(12), 1241. https://doi.org/10.3390/ph14121241
Publication Date